Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
Press releases published on August 13, 2025
National Healthcareer Association Launches New Membership Community Platform
GlobeNewswire
·
August 13, 2025
LEAWOOD, Kan., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The National Healthcareer Association (NHA), the largest allied health certification agency in the United States, today announced the launch of its NHA Membership Program Community platform, an initiative …
Telitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for Primary Sjögren's Disease with Telitacicept, a Dual BAFF/APRIL Inhibitor
GlobeNewswire
·
August 13, 2025
Phase 3 results position telitacicept as potential best-in-disease profile in primary Sjögren's disease Telitacicept demonstrated a favorable safety profile Vor evaluating timing of global Phase 3 clinical study in primary Sjögren's disease Data …
Smart Medical Devices Market to Grow at 17.1% CAGR Through 2030
GlobeNewswire
·
August 13, 2025
Boston, Aug. 13, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Smart Medical Devices: Global Markets” is projected to grow from $87.7 billion in 2025 to $193.3 billion by the end of 2030, at a compound annual growth rate (CAGR) …
Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership
GlobeNewswire
·
August 13, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
Center for Internet Security Selects Sophos as Premier Partner for Endpoint Security to Protect U.S. State and Local Government Organizations
GlobeNewswire
·
August 13, 2025
DALLAS, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Sophos, a global leader of innovative security solutions for defeating cyberattacks, today announced it has been selected by the Center for Internet Security, Inc. (CIS) as the endpoint protection provider for …
Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme
GlobeNewswire
·
August 13, 2025
First patient dosed with CUE-102 for recurrent glioblastoma multiforme (rGBM) at Dana-Farber Cancer Institute (DFCI) BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel …
Great Elm Capital Corp. Announces Amended and Upsized Revolving Credit Facility
GlobeNewswire
·
August 13, 2025
PALM BEACH GARDENS, Fla., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “our,” the “Company” or “GECC”) (NASDAQ: GECC), a business development company, today announced it has entered into an amendment to its revolving credit facility ( …
ElevateBio BaseCamp Achieves ICMC™ Certification for Commercial Cell and Gene Therapy Manufacturing Capabilities
GlobeNewswire
·
August 13, 2025
ICMC certification delivered by Dark Horse Consulting certifies ElevateBio’s compliant and scalable manufacturing capabilities for advanced therapies using U.S. and E.U. commercial-level evaluation standards BaseCamp is the first genetic medicine …
Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
More than 45 patients enrolled in Emi-Le Phase 1 dose expansion cohorts in post-topoisomerase-1 inhibitor ADC (post-topo-1) triple-negative breast cancer (TNBC) Plan to report initial clinical data from Emi-Le expansion cohorts in second half of 2025 …
Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
August 13, 2025
Continued Clinical Program Execution in the Phase 3 CoMpass Trial in Early Choroidal Melanoma and the Phase 1b/2 Trial in Non-Muscle Invasive Bladder Cancer (NMIBC) Strengthened Balance Sheet with $75 Million Equity Financing; Cash Position Expected to …
X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
GlobeNewswire
·
August 13, 2025
BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today closed an upsized private placement of 11,040,776 shares of common stock and pre- …
Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering
GlobeNewswire
·
August 13, 2025
BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today …